How much subsidy will chronic patients receive under the new tier?

Question

Accepted Answer

Chronic Patients to Receive Subsidies of Up to 87.5 Per Cent for Whitelisted Medications

Eligible Singaporeans with chronic conditions will benefit from enhanced subsidies under the new Healthier SG chronic tier, with financial support extending up to 87.5 per cent for whitelisted chronic drugs, contingent on their income levels. Beyond medication, these patients will also receive adjusted dollar-based subsidies amounting to S$360 annually for essential chronic care components, including consultations and laboratory tests. Furthermore, the cash co-payment requirement when utilising MediSave for chronic treatment will be eliminated, enabling full bill coverage up to the prescribed withdrawal limits.
Enhanced Medication Subsidies Based on Income

Under the forthcoming Healthier SG chronic tier, which is slated to commence in early next year, individuals diagnosed with chronic conditions can anticipate substantial subsidies for a curated list of medications. The subsidy rate can reach as high as 87.5 per cent, with the exact percentage determined by the patient's income bracket. This measure aims to ensure that the cost of whitelisted chronic drugs at participating Healthier SG general practitioner (GP) clinics becomes comparable to the prices available at polyclinics, thereby broadening access to necessary treatments.
Additional Financial Support for Broader Chronic Care

In addition to medication, the new Healthier SG chronic tier introduces dollar-based subsidies for other facets of chronic care. Patients enrolled in this programme can receive up to S$360 per year to offset costs associated with services such as medical consultations and laboratory tests. This holistic approach to financial assistance acknowledges the diverse needs of individuals managing long-term health conditions, extending support beyond pharmaceutical expenses.
Removal of Cash Co-payment for MediSave Usage

A significant financial relief for chronic patients involves the removal of the cash co-payment when using MediSave for their treatment expenses. Effective from early next year, patients will be able to utilise their MediSave funds to cover their medical bills entirely, subject to the prevailing withdrawal limits. This change eliminates the out-of-pocket cash expenditure previously required for a portion of the treatment costs, making healthcare more accessible and manageable.
MediSave Withdrawal Limits Remain Applicable

While the cash co-payment for chronic treatment using MediSave will be abolished, the usage of MediSave remains subject to annual withdrawal limits. For chronic patients, the yearly withdrawal limit is set at S$700 per individual. Non-chronic patients have a slightly lower annual limit of S$500 per individual. These limits ensure the sustainable use of MediSave funds for healthcare needs.

Reading history

Hide →

This history is cleared when the page is closed.

How much subsidy will chronic patients receive under the new tier?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends